Lenalidomide (Standard)
Based on 1 Customer Validation
Lenalidomide (Standard) (CC-5013 (Standard)) is the analytical standard of Lenalidomide (HY-A0003). This product is intended for research and analytical applications. Lenalidomide (CC-5013) is an orally active immunomodulatory agent that binds CRBN as a molecular glue to alter substrate specificity, inducing ubiquitination and proteasome-dependent degradation of IKZF1, IKZF3 and CK1α. Lenalidomide induces apoptosis by degrading IKZF1/3, and activates p53 by degrading CK1α. Lenalidomide promotes IL-2 release and effector functions of CD8+ T/NK cells, while inhibiting TNF-α secretion and M1-type pyroptosis. Lenalidomide can be used in research related to hematological malignancies, acute liver failure and acute kidney injury.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.98%
- CAS 番号: 191732-72-6
- 分子式: C13H13N3O3
- 分子量:259.26
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
化学情報
- 純度とドキュメンテーション
-
Help & FAQs
-
HY-10984
PomalidomideImmunomodulatory Agent -
HY-14658
ThalidomideCereblon Inhibitor -
HY-101291
IberdomideCELMoD -
HY-A0003
LenalidomideImmunomodulator -
HY-10984R
Pomalidomide (Standard)Immunomodulatory Agent -
HY-14658R
Thalidomide (Standard)Cereblon Inhibitor -
HY-130800
EragidomideGSPT1 Molecular Glue Degrader -
HY-100507
AvadomideCereblon Modulator -
HY-43722
Lenalidomide-Br -
HY-129395
MezigdomideCereblon E3 Ubiquitin Ligase Modulating Agent -
HY-15760
Necrostatin-1RIPK1 Inhibitor -
HY-W072954
Lenalidomide-5-Br
Product Information
説明
アプリケーション
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
化学情報
-
CAS 番号 191732-72-6
-
性状 Solid
-
分子量 259.26
-
分子式 C13H13N3O3
-
Color White to off-white
-
SMILES
O=C1C2=CC=CC(N)=C2CN1C(C(N3)=O)CCC3=O
-
別名
CC-5013 (Standard)
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
-
SDS (418 KB)
- English - EN (418 KB)
- Français - FR (418 KB)
- Deutsch - DE (418 KB)
- Norwegian - NO (418 KB)
- Español - ES (418 KB)
- Swedish - SV (418 KB)
- Italian - IT (418 KB)
- Korean - KR (418 KB)
- Portuguese - PT (418 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Krönke J, et al. Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS. Nature. 2015 Jul 9;523(7559):183-188. [Content Brief]
[2]. Minnie SA, et al. TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in mice. The Journal of clinical investigation. 2023 Feb 15;133(4):e157907. [Content Brief]
[3]. Wang Y, et al. TNF-α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury. Cell Prolif. 2020 Jun;53(6):e12829. [Content Brief]
[4]. Lu G, et al. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science (New York, N.Y.). 2014 Jan 17;343(6168):305-9. [Content Brief]
[5]. Rozewski DM, et al. Pharmacokinetics and tissue disposition of lenalidomide in mice. The AAPS journal. 2012 Dec;14(4):872-82. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Lenalidomide (Standard) 関連分類
HY-A0003R 関連分類
Powered by Bioz
Keywords
- Lenalidomide (Standard)
- 191732-72-6
- CC-5013 (Standard)
- Reference Standards
- Molecular Glues
- Ligands for E3 Ligase
- IKZF Family
- Casein Kinase
- Apoptosis
- Pyroptosis
- MDM-2/p53
- TNF Receptor
- KG-1 cells
- IKZF3
- cereblon
- M1 macrophages
- myelodysplastic syndrome
- multiple myeloma
- CK1α
- CD8+ T cell
- THP-1 cells
- IKZF1
- Inhibitor
- inhibitor
- inhibit